Mimi Zhou
No.2 Department of Geriatrics, Hangzhou Wenzhong Hospital, Hangzhou 310000, China
Siyuan Jing
No.2 Department of Geriatrics, Hangzhou Wenzhong Hospital, Hangzhou 310000, China
Yue Chen
No.2 Department of Geriatrics, Hangzhou Wenzhong Hospital, Hangzhou 310000, China
The dosing of anti-Parkinson drugs is considered as the optimal control of the symptoms of PD, and increasing the dose of drugs is a common method to treat the aggravate state of PD. However, this is a case of PD elderly patient who had nephritic syndrome, with an increase in the dose, the symptoms did not get improved, but a series of other adverse effects appeared.
[1] Silvia A Mandel, Only Weinreb, Tamar Amit, et al (2005) Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives. Brain Research Reviews 48: 379-87.
[2] Wichmann T, DeLong MR (2003) Functional neuroanatomy of the basal ganglia in Parkinson’s disease. Adv Neurol 91: 9-18.
[3] Brotchie JM, Lee J, and Venderova K (2005) Levodopa-induced dyskinesia in Parkinson’s disease. J Neural Transm 112: 359-91.
[4] Torsney KM, Forsyth D (2017) Breathing problems in Parkinson's disease: a common problem, rarely diagnosed. Atlas of Science another view on science http://atlasofscience.org
Aims and Scope